Christopher Bowden Alaunos Therapeutics, Inc. (TCRT) insider trading activity
Christopher Bowden is Director of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 44,167 shares of TCRT, which is worth approximately $106,884. The most recent transaction as insider was on Jun 22, 2022, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
44.2K
0%
3M change
0%
12M change
Total Value Held
$106,884
Christopher Bowden Transaction History
Also insider at
CB
Christopher Bowden
Director
Cambridge, MA